128 related articles for article (PubMed ID: 33492853)
1. FDG PET/CT of an Advanced Case of Malignant Nerve Sheath Tumor of Pleura.
Saidi B; Fallahi B; Abdi A; Rakhshani N; Eftekhari M
Clin Nucl Med; 2021 Mar; 46(3):246-247. PubMed ID: 33492853
[TBL] [Abstract][Full Text] [Related]
2. Solitary Malignant Peripheral Nerve Sheath Tumor of Lumbar Vertebra Mimicking Metastatic Malignancy.
Guo Z; Liu W; Dong Z; Yang L; Xie P
Clin Nucl Med; 2023 May; 48(5):435-436. PubMed ID: 36800240
[TBL] [Abstract][Full Text] [Related]
3. Malignant Peripheral Nerve Sheath Tumor Arising From Transplanted Kidney Assessed by 18F-FDG PET/CT.
Feng H; Tu N; Bu L
Clin Nucl Med; 2020 Nov; 45(11):905-907. PubMed ID: 32969901
[TBL] [Abstract][Full Text] [Related]
4. Malignant Peripheral Nerve Sheath Tumor With Bilateral Adrenal Metastases: Role of 18F-FDG PET/CT in Response Assessment to Tyrosine Kinase Inhibitor and Liposomal Doxorubicin.
Tripathy S; Passah A; Singhal A; Prashanth A; Kumar R
Clin Nucl Med; 2019 Jun; 44(6):494-495. PubMed ID: 30889004
[TBL] [Abstract][Full Text] [Related]
5. A Rare Case of Primary Pleura Myxoid Leiomyosarcoma: FDG PET/CT Finding.
Wang L; Ren Y; Ding X; Dong C; Liu J
Clin Nucl Med; 2020 Apr; 45(4):316-318. PubMed ID: 32049732
[TBL] [Abstract][Full Text] [Related]
6. A rare primary pleural squamous cell carcinoma demonstrated on
Xiao L; Zhang WJ; Li L
Hell J Nucl Med; 2020; 23(1):86-87. PubMed ID: 32222735
[TBL] [Abstract][Full Text] [Related]
7. Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Bertagna F; Bosio G; Biasiotto G; Savelli G; Rodella C; Giubbini R; Rosenbaum J; Alavi A
Jpn J Radiol; 2009 Oct; 27(8):320-3. PubMed ID: 19856228
[TBL] [Abstract][Full Text] [Related]
8. Incidental finding of Psuedomyxoma Peritonei in Malignant Peripheral Nerve Sheath Tumour.
Gill SM; Waseem M; Bashir H; Hassan A
J Pak Med Assoc; 2024 May; 74(5):1007-1008. PubMed ID: 38783460
[TBL] [Abstract][Full Text] [Related]
9. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
[TBL] [Abstract][Full Text] [Related]
11. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
Kitajima K; Doi H; Kuribayashi K
Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
[TBL] [Abstract][Full Text] [Related]
12. Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma.
Strange CD; Marom EM; Ahuja J; Shroff GS; Gladish GW; Carter BW; Truong MT
Adv Anat Pathol; 2023 Jul; 30(4):280-291. PubMed ID: 36395181
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT Helps Differentiate Peripheral Nerve Myeloid Sarcoma From a Presumed Benign Nerve Sheath Tumor.
Das JP; Riedl CC; Ulaner GA
Clin Nucl Med; 2020 Dec; 45(12):989-991. PubMed ID: 32956122
[TBL] [Abstract][Full Text] [Related]
14. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
Benz MR; Czernin J; Dry SM; Tap WD; Allen-Auerbach MS; Elashoff D; Phelps ME; Weber WA; Eilber FC
Cancer; 2010 Jan; 116(2):451-8. PubMed ID: 19924789
[TBL] [Abstract][Full Text] [Related]
15. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology.
Gerbaudo VH; Sugarbaker DJ; Britz-Cunningham S; Di Carli MF; Mauceri C; Treves ST
J Nucl Med; 2002 Sep; 43(9):1144-9. PubMed ID: 12215551
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of malignant pleural and pericardial disease on FDG PET/CT.
Makis W; Ciarallo A; Hickeson M; Rush C; Novales-Diaz JA; Derbekyan V; Laufer J; Stern J; Lisbona R
AJR Am J Roentgenol; 2012 Mar; 198(3):678-85. PubMed ID: 22358009
[TBL] [Abstract][Full Text] [Related]
18. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
[TBL] [Abstract][Full Text] [Related]
19. Is FDG-PET/CT useful for managing malignant pleural mesothelioma?
Otsuka H; Terazawa K; Morita N; Otomi Y; Yamashita K; Nishitani H
J Med Invest; 2009 Feb; 56(1-2):16-20. PubMed ID: 19262009
[TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.
Chander S; Westphal SM; Zak IT; Bloom DA; Zingas AP; Joyrich RN; Littrup PJ; Taub JW; Getzen TM
Clin Nucl Med; 2004 Jul; 29(7):415-8. PubMed ID: 15192465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]